Ashwagandha + Rhodiola + L-Theanine: The Adaptogen Trio

The adaptogen trio of ashwagandha (KSM-66), rhodiola (Rhodiola rosea, 3% rosavins) and L-theanine (Camellia sinensis, 40%) covers three complementary axes of the chronic stress response: cortisol and sleep (ashwagandha), mental fatigue and cognition under pressure (rhodiola), and cerebral alpha waves and alert relaxation without drowsiness (L-theanine). Each component has its own body of clinical evidence, and the rationale for combining them in a single formula rests on the complementarity of their mechanisms — not on a synergy documented in clinical trials of the combination itself. This article explains the individual profiles, the logic behind combining them, the honest nuances around “synergy,” and when it makes sense to consider each one separately or together.

What is an adaptogen and why combine them?

The concept of the adaptogen was formulated in the USSR in the 1940s by pharmacologist Nikolai Lazarev and further developed by Israel Brekhman. It defines natural substances with three main pharmacological traits: bidirectional modulation of the stress response, relative safety with prolonged use at customary doses, and a non-specific increase in resistance to physical, chemical and biological stressors.

All three components of the Pleniage trio fit this profile but cover different axes of chronic stress:

• Ashwagandha: focused on the hypothalamic–pituitary–adrenal (HPA) axis, cortisol and sleep.
• Rhodiola: focused on mental fatigue and cognitive performance under pressure.
• L-theanine: focused on alert relaxation without drowsiness (cerebral alpha waves).

The rationale for combining them is not to chase “the same effect multiplied” but to cover several axes of the complex symptom picture of sustained chronic stress, where elevated cortisol + mental tiredness + difficulty “switching off” without losing clarity often coincide.

Ashwagandha (KSM-66): cortisol, calm and sleep

Ashwagandha (Withania somnifera) is the adaptogen with the largest body of published human clinical trials on physiological markers of stress. The reference standardized form is KSM-66 (pure root at 5% withanolides, a patented extract from Ixoreal Biomed).

The study by Lopresti and colleagues published in Medicine (Baltimore) in 2019 documented that a standardized ashwagandha extract at 240 mg/day for 60 days reduced morning serum cortisol by roughly 23% in people with self-perceived chronic stress. The trial by Salve and colleagues published in Cureus in 2019 documented improvements in subjective sleep quality (assessed with a self-reported sleep scale) at doses of 250 and 600 mg/day over 8 weeks.

For the full profile, see the Ashwagandha KSM-66 fact sheet.

Rhodiola (R. rosea, 3% rosavins): mental fatigue and cognition

Rhodiola (Rhodiola rosea) is an adaptogen whose profile is oriented toward mental fatigue linked to sustained stress and cognitive performance under pressure. The reference standardized form is the extract at 3% rosavins and 1% salidrosides.

The trial by Olsson and colleagues published in Planta Medica in 2009 documented significant improvements on fatigue scales (Pines Burnout Inventory) and concentration capacity with the SHR-5 extract at 576 mg/day for 28 days in people with stress-related fatigue. The trial by Spasov and colleagues published in Phytomedicine in 2000 documented improvements in cognitive performance in students during an exam period (a real-world setting of sustained cognitive demand).

For the full profile, see the Rhodiola fact sheet and the dedicated article Rhodiola for mental fatigue.

L-theanine (Camellia sinensis, 40%): alpha waves and alert relaxation

L-theanine is a non-proteinogenic amino acid found naturally in the leaves of green tea (Camellia sinensis). The L-theanine in PLENIAGE® L-Theanine comes from an extract standardized to 40% theanine with no EGCG (epigallocatechin gallate) — a profile that preserves the effects attributed to theanine without the polyphenol load tied to the 2018 EFSA alerts on concentrated green tea extracts.

The study by Nobre and colleagues published in the Asia Pacific Journal of Clinical Nutrition in 2008 documented, using human EEG (electroencephalogram) recordings, that L-theanine — already at 50 mg (a dietarily realistic dose) — increases cerebral alpha waves (8–13 Hz), an EEG pattern associated with a state of “alert relaxation,” distinct from drowsiness (theta waves) or deep sleep (delta waves). The trial by Hidese and colleagues published in Nutrients in 2019 documented improvements on stress scales (STAI, the State-Trait Anxiety Inventory) and subjective sleep quality with L-theanine at 200 mg/day over 4 weeks.

For the full profile, see the L-theanine fact sheet.

Three complementary, non-redundant mechanisms

The three components act through distinct but compatible mechanisms:

• Ashwagandha → modulation of the HPA axis (research examines its relationship with cortisol and sleep quality).
• Rhodiola → modulation of monoaminergic neurotransmitters (serotonin, dopamine, noradrenaline) + activation of cellular stress proteins (Hsp70) + possible AMPK/mTOR modulation.
• L-theanine → modulation of the GABA/glutamate balance + an increase in cerebral alpha waves.

This mechanistic diversity is the main argument in favor of combining them in a single formula: together they cover several axes of the complex symptom picture of sustained stress at once.

Documented synergy vs inferred synergy: the honest nuance

Here it pays to be honest about what the evidence does and does not show. The real picture is:

• Each of the three components has its own body of clinical evidence: ashwagandha (cortisol, sleep, stress markers), rhodiola (mental fatigue, cognition), L-theanine (alert relaxation, subjective sleep, attention).
• The specific combination of the three has NOT been the subject of its own controlled clinical trial with enough statistical power to conclude documented synergy. What exists is the reasonable inference that complementary mechanisms may have additive effects on multidimensional symptoms.
• The difference between “mechanistic complementarity” and “synergy documented in a clinical trial of the combination” matters. The former is a reasonable hypothesis grounded in biochemical knowledge; the latter requires a specific randomized trial that has not yet been carried out for this particular combination.

In practice, the combination is reasonable when the consumer’s profile spans several axes at once (elevated perceived cortisol + mental tiredness + difficulty switching off without losing clarity), but presenting the formula as “documented synergy” would go beyond what the evidence supports.

Studied doses and time of day for each one

• Ashwagandha (KSM-66): 250–600 mg/day. Flexible timing — evening if the focus is sleep, morning if the focus is daytime cortisol.
• Rhodiola (3% rosavins): 200–400 mg/day. Morning or midday (an activating component — avoid late evening).
• L-theanine (40% theanine): 100–200 mg/day. Flexible timing — paired with morning caffeine, or in the evening to support sleep.

When combined in a single formula, the individual doses usually sit in the low-to-mid range of the interval studied for each one (stacking adaptogens at their maximum doses can be excessive). Well-designed professional formulas balance the three components at sensible doses.

When it makes sense to combine them (profiles)

• Sustained chronic stress with multidimensional symptoms: elevated perceived cortisol + mental tiredness + difficulty falling asleep + tension without clinical anxiety.
• Professionals with sustained cognitive demand (consulting, research, teaching, creative work) who also carry a high level of nervous activation.
• Life transitions involving sustained stress (job changes, moving house, separations, non-pathological grief).
• People who already use caffeine and feel the jittery edge without getting the sustained performance they expected — the rhodiola + L-theanine combination can modulate both extremes.

When NOT to combine them

• Pregnancy and breastfeeding: all three components are contraindicated as a general precaution.
• Bipolar disorder: rhodiola is contraindicated because of a theoretical risk of precipitating manic episodes through its activating component. By extension, the combination is too.
• Active autoimmune diseases: ashwagandha has immunomodulatory activity and should be avoided or used under specialist supervision.
• Treatment with antidepressants (especially MAOIs, monoamine oxidase inhibitors; with SSRIs, selective serotonin reuptake inhibitors, explicit psychiatric supervision is required): rhodiola acts on monoaminergic neurotransmitters.
• Uncontrolled hyperthyroidism: ashwagandha can modulate thyroid function.
• Surgery scheduled within <2 weeks: discontinue all three components because of their effect on the central nervous system.
• Complex polypharmacy: if you take several long-term medications, pharmacist/physician assessment is mandatory before adding combined adaptogens, especially with anticoagulants, antidiabetics, antihypertensives or sedatives.

The trio in the Pleniage portfolio (Pro Calm+)

The adaptogen trio is included in the formulation of PLENIAGE® Pro Calm+ alongside Albion TRAACS® magnesium bisglycinate and B-group vitamins (B6, B9, B12). The formula combines:

• Ashwagandha KSM-66 ORGANIC (pure root, 5% withanolides, organic certification)
• Rhodiola at 3% rosavins (the clinical reference standardization)
• L-theanine without EGCG (Camellia sinensis at 40% theanine)
• Albion TRAACS® magnesium bisglycinate (high bioavailability + glycine with a mildly calming profile)
• Vitamins B6 + B9 + B12 (cofactors of the methyl cycle)

Each ingredient has its own individual scientific research; the specific combination in this formula has not been the subject of its own clinical trial. The rationale for combining them rests on the mechanistic complementarity described in this article, not on a synergy documented in a controlled trial.

This page is part of the Calm and balance cluster. To go deeper into each component individually or into other aspects of sustained stress, see also the article Stress, cortisol and cholesterol, the guide Can stress raise cholesterol and the magnesium bisglycinate vs citrate comparison.

The adaptogen trio (ashwagandha + rhodiola + L-theanine) covers three complementary axes of the chronic stress response (cortisol and sleep + mental fatigue and cognition + alpha waves and alert relaxation). Each component has its own reasonable body of clinical evidence; the specific combination has not been the subject of a controlled clinical trial, but its mechanistic inference is coherent. It’s reasonable to consider it when the consumer’s profile spans several axes at once; it is NOT reasonable to present it as “documented synergy,” because that would go beyond what the evidence supports. The individual contraindications of each component (especially pregnancy, bipolar disorder, autoimmune conditions, polypharmacy) apply equally to the combination.

At PLENIAGE® we publish scientific content on evidence-based supplementation. You can explore the Calm and balance cluster for more fact sheets and related articles.